Quick Answer
HAEMONETICS CORP reported Net Income Loss of $167.68 million for the year ending 2025.
- HAEMONETICS CORP showed an increase of +42.6% in Net Income Loss from 2024 to 2025.
- This data is from HAEMONETICS CORP's annual report (Form 10-K), filed with the SEC on May 21, 2025.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), HAEMONETICS CORP's Net Income Loss has grown by 182.7%.
- Historical annual values: Fiscal year 2025: $167.68 million | Fiscal year 2024: $117.56 million | Fiscal year 2023: $115.40 million | Fiscal year 2022: $43.38 million | Fiscal year 2021: $79.47 million | Fiscal year 2020: $76.53 million | Fiscal year 2019: $55.02 million | Fiscal year 2018: $45.57 million | Fiscal year 2017: -$26.27 million | Fiscal year 2016: -$55.58 million | Fiscal year 2015: $16.90 million | Fiscal year 2014: $35.15 million | Fiscal year 2013: $38.80 million | Fiscal year 2012: $66.89 million | Fiscal year 2011: $79.98 million | Fiscal year 2010: $58.37 million | Fiscal year 2009: $59.30 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: